New Retina Radio:

The Art of Drug Choice

The Art of Drug Choice logo.

11.19.20

The Art of Drug Choice: Wet AMD and the Latest Data

Arshad M. Khanani, MD, MA, leads a roundtable consisting of Christopher G. Fuller, MD; Nikolas J.S. London, MD, FACS; and Christina Y. Weng, MD, MBA, as they discuss the art of drug choice in wet AMD therapy. The panel discusses how and why they switch therapy in challenging wet AMD cases and reviews how the COVID-19 pandemic has factored into their treatment algorithms. Also, Dr. Fuller shares the case of a wet AMD patient whose waning response to traditional therapy required intervention with an intravitreal dexamethasone implant (Ozurdex, Allergan).  This editorially independent podcast is supported with advertising.

Other Podcast Episodes

03.24.22

Art of Drug Choice: Treating New Wet AMD Patients

Arshad M. Khanani, MD, MA; Lejla Vajzovic, MD, and Joseph M. Coney, MD

03.17.22

Art of Drug Choice: Who Is Best Suited for Extended-duration Therapy?

Arshad M. Khanani, MD, MA; Lejla Vajzovic, MD; and Joseph M. Coney, MD

03.03.22

Art of Drug Choice: The Latest Advances in Wet AMD Therapy

Arshad M. Khanani, MD, MA; Lejla Vajzovic, MD, and Joseph M. Coney, MD

09.10.21

The Art of Drug Choice: International Panel in Wet AMD: Safety Data

Arshad M. Khanani, MD; Justus G. Garweg, MD; Seenu M. Hariprasad, MD; Peter Kertes, MD, FRCSC

09.01.21

The Art of Drug Choice: International Panel in Wet AMD: The Pipeline

Arshad M. Khanani, MD; Justus G. Garweg, MD; Seenu M. Hariprasad, MD; Peter Kertes, MD, FRCSC

08.20.21

The Art of Drug Choice: International Panel in Wet AMD: Phase 3 and Real-World Data to Watch

Arshad Khanani, MD, MA; Justus Garweg, MD; Seenu Hariprasad, MD; Peter Kertes, MD, FRCSC

08.06.21

The Art of Drug Choice: International Panel in Wet AMD: When and Why Switching Therapy Makes Sense

Arshad M. Khanani, MD, MA; Justus G. Garweg, MD; Seenu M. Hariprasad, MD; and Peter Kertes, MD, FRCSC

11.19.20

The Art of Drug Choice: Safety in Wet AMD

Arshad M. Khanani, MD, MA; Christopher G. Fuller, MD; Nikolas J.S. London, MD, FACS; and Christina Y. Weng, MD, MBA

11.19.20

The Art of Drug Choice: Wet AMD Pipeline

Arshad M. Khanani, MD, MA; Christopher G. Fuller, MD; Nikolas J.S. London, MD, FACS; and Christina Y. Weng, MD, MBA

11.19.20

The Art of Drug Choice: Phase 3 Trials in Wet AMD

Arshad M. Khanani, MD, MA; Christopher G. Fuller, MD; Nikolas J.S. London, MD, FACS; and Christina Y. Weng, MD, MBA